These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32581261)

  • 81. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.
    Chirkova T; Boyoglu-Barnum S; Gaston KA; Malik FM; Trau SP; Oomens AG; Anderson LJ
    J Virol; 2013 Dec; 87(24):13466-79. PubMed ID: 24089561
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparing respiratory syncytial virus and rhinovirus in development of post-viral airway disease.
    Narayanan D; Grayson MH
    J Asthma; 2022 Mar; 59(3):434-441. PubMed ID: 33345668
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Airway epithelial cell-induced activation of monocytes and eosinophils in respiratory syncytial viral infection.
    Becker S; Soukup JM
    Immunobiology; 1999 Sep; 201(1):88-106. PubMed ID: 10532283
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Systemic T-helper and T-regulatory cell type cytokine responses in rhinovirus vs. respiratory syncytial virus induced early wheezing: an observational study.
    Jartti T; Paul-Anttila M; Lehtinen P; Parikka V; Vuorinen T; Simell O; Ruuskanen O
    Respir Res; 2009 Sep; 10(1):85. PubMed ID: 19781072
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Influenza A virus abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak/Stat pathway.
    Uetani K; Hiroi M; Meguro T; Ogawa H; Kamisako T; Ohmori Y; Erzurum SC
    Eur J Immunol; 2008 Jun; 38(6):1559-73. PubMed ID: 18493979
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Post-viral atopic airway disease: pathogenesis and potential avenues for intervention.
    Hussain SA; Mejias A; Ramilo O; Peeples ME; Grayson MH
    Expert Rev Clin Immunol; 2019 Jan; 15(1):49-58. PubMed ID: 30370798
    [No Abstract]   [Full Text] [Related]  

  • 87. RSV Reprograms the CDK9•BRD4 Chromatin Remodeling Complex to Couple Innate Inflammation to Airway Remodeling.
    Brasier AR
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32331282
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inducible GBP5 Mediates the Antiviral Response via Interferon-Related Pathways during Influenza A Virus Infection.
    Feng J; Cao Z; Wang L; Wan Y; Peng N; Wang Q; Chen X; Zhou Y; Zhu Y
    J Innate Immun; 2017; 9(4):419-435. PubMed ID: 28376501
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of exogenous interferons on rhinovirus replication and airway inflammatory responses.
    Becker TM; Durrani SR; Bochkov YA; Devries MK; Rajamanickam V; Jackson DJ
    Ann Allergy Asthma Immunol; 2013 Nov; 111(5):397-401. PubMed ID: 24125148
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication.
    Lee JS; Lee YN; Lee YT; Hwang HS; Kim KH; Ko EJ; Kim MC; Kang SM
    Nutrients; 2015 Feb; 7(2):1021-36. PubMed ID: 25658239
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response.
    Lay MK; González PA; León MA; Céspedes PF; Bueno SM; Riedel CA; Kalergis AM
    Microbes Infect; 2013 Mar; 15(3):230-42. PubMed ID: 23246463
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD.
    Baines KJ; Hsu AC; Tooze M; Gunawardhana LP; Gibson PG; Wark PA
    Respir Res; 2013 Feb; 14(1):15. PubMed ID: 23384071
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of Clinical, Demographic Features, and Costs in Respiratory Syncytial Virus, Rhinovirus, and Viral Co-infections in Children Hospitalized with Viral Infections of the Lower Respiratory Tract.
    Ekinci Sert S; Karagol C; Gungor A; Gulhan B
    Jpn J Infect Dis; 2022 Mar; 75(2):164-168. PubMed ID: 34470965
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium.
    Guo-Parke H; Linden D; Weldon S; Kidney JC; Taggart CC
    Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056429
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ficus religiosa L. bark extracts inhibit human rhinovirus and respiratory syncytial virus infection in vitro.
    Cagno V; Civra A; Kumar R; Pradhan S; Donalisio M; Sinha BN; Ghosh M; Lembo D
    J Ethnopharmacol; 2015 Dec; 176():252-7. PubMed ID: 26528588
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
    Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling.
    Jia D; Rahbar R; Chan RW; Lee SM; Chan MC; Wang BX; Baker DP; Sun B; Peiris JS; Nicholls JM; Fish EN
    PLoS One; 2010 Nov; 5(11):e13927. PubMed ID: 21085662
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.
    Mordstein M; Neugebauer E; Ditt V; Jessen B; Rieger T; Falcone V; Sorgeloos F; Ehl S; Mayer D; Kochs G; Schwemmle M; Günther S; Drosten C; Michiels T; Staeheli P
    J Virol; 2010 Jun; 84(11):5670-7. PubMed ID: 20335250
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.
    Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z
    Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ.
    Jacobs S; Wavreil F; Schepens B; Gad HH; Hartmann R; Rocha-Pereira J; Neyts J; Saelens X; Michiels T
    J Interferon Cytokine Res; 2018 Nov; 38(11):469-479. PubMed ID: 30335553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.